3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro‐organisms (excluding yeasts) and similar products ▸ Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale
MaxNOMManufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided their total value does not exceed 20% of the ex‐works price of the product.
20% ex-works 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro‐organisms (excluding yeasts) and similar products ▸ Human blood
MaxNOMManufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided their total value does not exceed 20% of the ex‐works price of the product.
20% ex-works 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro‐organisms (excluding yeasts) and similar products ▸ Animal blood prepared for therapeutic or prophylactic uses
MaxNOMManufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided their total value does not exceed 20% of the ex‐works price of the product.
20% ex-works 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro‐organisms (excluding yeasts) and similar products ▸ Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins
MaxNOMManufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided their total value does not exceed 20% of the ex‐works price of the product.
20% ex-works 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro‐organisms (excluding yeasts) and similar products ▸ Haemoglobin, blood globulins and serum globulins
MaxNOMManufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided their total value does not exceed 20% of the ex‐works price of the product.
20% ex-works 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro‐organisms (excluding yeasts) and similar products ▸ Other
MaxNOMManufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided their total value does not exceed 20% of the ex‐works price of the product.
20% ex-works 3002Other heterocyclic compounds with nitrogen heteroatom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, in the form of peptides and proteins which are directly involved in the regulation of immunological processes
MaxNOMManufacture from materials of any heading. However, the value of all the materials of heading 2932 and heading 2933 used may not exceed 20% of the ex‐works price of the product.
20% ex-works MaxNOMManufacture in which the value of all the materials used does not exceed 40% of the ex‐works price of the product.
40% ex-works 3002Other nucleic acids and their salts, whether or not chemically defined, in the form of peptides and proteins which are directly involved in the regulation of immunological processes; other heterocyclic compounds, in the form of peptides and proteins which are directly involved in the regulation of immunological processes
MaxNOMManufacture from materials of any heading. However, the value of all the materials of heading 2932, heading 2933 and heading 2934 used may not exceed 20% of the ex‐works price of the product.
20% ex-works MaxNOMManufacture in which the value of all the materials used does not exceed 40% of the ex‐works price of the product.
40% ex-works 3002Any other product from heading 3002
MaxNOMManufacture in which all the materials used are classified within a heading other than that of the product. However, materials classified within the same heading may be used provided their value does not exceed 20% of the ex‐works price of the product.
20% ex-works